(Q43597840)

25 November 2017

title

Tissue effects of saw palmetto and finasteride: use of biopsy cores for in situ quantification of prostatic androgens (English)

1 reference

25 November 2017

0 references

L S Marks

1

1 reference

25 November 2017

D L Hess

2

1 reference

25 November 2017

F J Dorey

3

1 reference

25 November 2017

M Luz Macairan

4

1 reference

25 November 2017

P B Cruz Santos

5

1 reference

25 November 2017

V E Tyler

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

57

1 reference

25 November 2017

issue

5

1 reference

25 November 2017

page(s)

999-1005

1 reference

Phytotherapy in treatment of benign prostatic hyperplasia: a critical review

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901052-9

7 January 2021

Saw palmetto for the treatment of men with lower urinary tract symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901052-9

7 January 2021

Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901052-9

7 January 2021

Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901052-9

7 January 2021

Prostate tissue composition and response to finasteride in men with symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901052-9

7 January 2021

Effects of long-term treatment with Serenoa repens (Permixon) on the concentrations and regional distribution of androgens and epidermal growth factor in benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901052-9

7 January 2021

Effects of the sabal serrulata extract IDS 89 and its subfractions on 5 alpha-reductase activity in human benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901052-9

7 January 2021

Inhibition of androgen metabolism and binding by a liposterolic extract of "Serenoa repens B" in human foreskin fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901052-9

7 January 2021

Comparison of finasteride (Proscar), a 5 alpha reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5 alpha reductase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901052-9

7 January 2021

Estrogens in fetal and maternal plasma of the rhesus monkey,.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901052-9

7 January 2021

A Quantitative Analysis of the Physiological Role of Estradiol and Progesterone in the Control of Tonic and Surge Secretion of Luteinizing Hormone in the Rat*

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901052-9

7 January 2021

Sex steroids in the umbilical circulation of fetal rhesus monkeys from the time of gonadal differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901052-9

7 January 2021

Prostatic effects induced in dogs by chronic or acute oral administration of 5 alpha-reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901052-9

7 January 2021

Finasteride, an inhibitor of 5 alpha-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901052-9

7 January 2021

Dihydrotestosterone measured in core biopsies from prostatic tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901052-9

7 January 2021

The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901052-9

7 January 2021

The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901052-9

7 January 2021

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2800%2901052-9

7 January 2021

10.1016/S0090-4295(00)01052-9

Identifiers

DOI

1 reference

25 November 2017

1 reference